Rhön Kinikum’s H1 15 results show sales of €555.4m, EBITDA of €83.8m, EBIT of €53.8m and net income of €48.6m (group share). Note figures are of course not comparable to last year’s given the huge change in scope after the disposal of the hospitals sold to Fresenius/Helios and still consolidated over two months in H1 14. The group maintains its target for FY15 of revenues of €1.08-1.12bn and EBITDA of €145-155m.
06 Aug 2015
H1 15 in line, a small acquisition and a share buy-back soon
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
H1 15 in line, a small acquisition and a share buy-back soon
RHON-KLINIKUM AG (RHK:WBO) | 0 0 0.1% | Mkt Cap: 1,945m
- Published:
06 Aug 2015 -
Author:
Fabrice Farigoule -
Pages:
2
Rhön Kinikum’s H1 15 results show sales of €555.4m, EBITDA of €83.8m, EBIT of €53.8m and net income of €48.6m (group share). Note figures are of course not comparable to last year’s given the huge change in scope after the disposal of the hospitals sold to Fresenius/Helios and still consolidated over two months in H1 14. The group maintains its target for FY15 of revenues of €1.08-1.12bn and EBITDA of €145-155m.